Lab Automation Market

Lab Automation Market Analysis by Product (Lab Automation Equipment, Microplate Readers, Automated ELISA Systems), by Application (Drug Discovery, Clinical Diagnostics, Genomics Solutions, Proteomics Solutions), by End User, by Region - Global Insights 2022 to 2032

Analysis of Lab Automation market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Lab Automation Market Overview (2022 to 2032)

Worldwide demand for total lab automation services experienced a Y-o-Y expansion rate of over11%in 2022 compared to 2021, rising fromUS$ 1.8 BilliontoUS$ 2 Billion. The global lab automation market is segmented into various application, including drug discovery, clinical diagnostics, genomics solutions, and proteomics solutions. Among all the application, clinical diagnostics segment shall dominate the market, accounting for 27.1% of total revenue in 2022.

Going forward, the global lab automation market size is anticipated to grow significantly, with a compound annual growth rate (CAGR) of 7% from 2022 to 2032, and is projected to reach from US$ 1.8 billion in 2021 to US$ 4 billion in 2032.

Report Attributes Details
Anticipated Base Year Value (2021) US$ 1.8 Billion
Expected Market Value (2022) US$ 2 Billion
Projected Forecast Value (2032) US$ 3.93 Billion
Global Growth Rate (2022 to 2032) 7%
Expected Market CAGR for North America (2022 to 2032) 5.3%
Anticipated Growth Rate of Asia Pacific (2022 to 2032) 7.3%
Major Lab Automation Companies Thermo Fisher Scientific; Agilent Technologies; PerkinElmer; Hudson Robotics; Qiagen NV; F. Hoffmann-La Roche Ltd.; Hamilton Robotics; Siemens Healthineers; Becton Dickinson and Company; Bio-Rad Laboratories; FORMULATRIX; BioMerieux SA; Danaher Corporation

Don't Need a Global Report?

save 40%! on Country & Region specific reports

2015 to 2021 Revenue Analysis of Lab Automation vs. Future Outlook 2022 to 2032

From 2015 to 2021, the global lab automation market expanded at a CAGR of 6.1%. The automation in clinical laboratory accounts for the vast majority of the global market. Factors such as an aging population with rising healthcare costs, an increase in the prevalence of infectious diseases, an increase in the number of clinical studies, and advancements in lab automation technologies propelled the lab automation market growth during the historical period.

Amid the COVID-19 pandemic, testing volumes experienced a massive upsurge, prompting key healthcare providers to deploy highly precision-based diagnostic and treatment solutions, widening demand for laboratory automation solutions throughout 2020 and most of 2021. It is anticipated that the global pharmaceutical industry shall surpass US$ 1 Trillion by 2025. As manufacturers continue to rely on innovations with respect to therapeutic approaches, demand for automation is bound to aggrandize.

Demand for lab automation is likely to be fulfilled by rising government initiatives in the form of financial and technical aid to facilitate development of automated laboratories in key markets. According to market research and competitive intelligence provider Fact.MR, demand for lab automation is bound to expand nearly 2x during the forecast period ranging from 2022 to 2032.

Prominent Growth Drivers influencing Lab Automation Deployment

Expanding use of Lab Automation in Large Integrated Health Systems

Because of higher rates of growth in molecular-based diagnosis, quality improvements, an increasing number of partnerships, and healthcare modernization in these countries, emerging Asia Pacific countries such as China and India are the major countries for investment opportunities.

To increase revenue share, medical device manufacturing companies are focusing on the development of automated devices used for in-vitro diagnosis and research, with advanced facilities, which will indirectly drive the lab automation market growth and boost revenue from software and services over the forecast period. Furthermore, an increase in the number of government initiatives to improve healthcare infrastructure in Saudi Arabia and the UAE is expected to drive demand for lab automation solutions.

End-user demand for high-end, advanced lab automation devices from pharmaceutical and biotechnology companies, hospitals and diagnostics centers, ambulatory surgical centers, educational institutes, and research organizations for improved output and performance will create opportunities for the market launch of novel lab automation techniques and services in the long run.

Growing Acceptance of Laboratory Automation is propelling Market Growth

Over the last decade, the use of lab automation services has skyrocketed. Lab automation services aid in increasing throughput at an astounding rate, while also ensuring precise motion and consistency in report generation. With the introduction of automation techniques, the growing number of diagnosis cases and real-time result analysis has resulted in a threefold increase in demand for automated devices, advanced software, and services.

Another factor that is expected to have a significant impact on market growth in the near future is an increase in demand for miniaturization. One of the primary reasons for the implementation of automated systems and workstations in clinical laboratories is to allow for the miniaturization of research processes in order to develop solutions for various complex lab automation tasks in applications such as biotechnology, microbiology, and clinical chemistry, among others. Furthermore, miniaturization of these processes allows for easy cell expansion, monitoring, and cultivation, resulting in faster turn-around times in point-of-care settings.

In order to gain maximum market share, several players in the market are focusing heavily on new automated device launches and services to reduce the costs of lab automation services. Acquisitions, mergers, strategic collaborations, and technological advancements all play important roles in the growth of the lab automation market.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Factors likely to Impede Market Growth of Lab Automation

Small and Medium-Sized Laboratories have been Slow to adopt Automation

Many small and medium-sized laboratories find it difficult to invest in automation due to financial constraints. The high maintenance and service costs associated with laboratory informatics solutions are also a significant impediment.

According to industry experts, the cost of maintaining IT solutions exceeds the cost of the software itself. Moreover, low risk-taking capability and lack of evidence on the cost-effectiveness of automation solutions for small and medium-sized laboratories are restraining the growth of the lab automation market.

Region-wise Analysis

How will the Lab Automation Industry Grow in the Asia Pacific?

From 2022 to 2032, the lab automation market is expected to grow at a rate of 7.3%. The growing geriatric population is fueling the growth of the market. Because of the attractiveness of the medical sector, Japan dominates the lab automation market due to growing research and development in the pharmaceutical industry. Additionally, government initiatives to reduce healthcare spending will drive the growth of the market during the forecast period.

Because of the growing demand for multiple vaccines around the world, India is expected to witness significant growth in the lab automation market. Furthermore, Indian drugs are exported to over 200 countries, with the United States serving as the primary distribution market. This increases demand for laboratory automation systems while also propelling the laboratory automation market forward in India.

How Will North America Provide Growth Opportunities for Lab Automation Providers?

The lab automation market is expected to grow during the forecast period of 2022 to 2032. Fact.MR forecasts the market to reach a value of US$ 3.87 Billion and grow at a CAGR of 5.3% during the forecast period. The market is being driven by a surge in the adoption of the miniaturization process, which results in low reagent costs and high productivity.

During the forecast period, North America is expected to lead the market. Because of the presence of large pharmaceutical companies, the market for drug discovery and genomics is seeing increased investment.

The US market for biopharmaceuticals is the largest, accounting for nearly one-third of the global market.

Furthermore, according to the Pharmaceutical Research and Manufacturers Association (PhRMA), US firms conduct 50% of global R&D in pharmaceuticals, amounting to US$ 75 Billion. Furthermore, the United States has one of the most supportive domestic environments in the world for pharmaceutical development and commercialization, with few market barriers.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Category wise Insights

Which is the Dominant Lab Automation Application Area?

Clinical Diagnostics to emerge as a prominent Revenue Engine

According to Fact.MR, the clinical diagnostics segment shall dominate the market, accounting for 27.1% of total revenue in 2022. This high share can be attributed to technological advancements, an increase in automated systems offered by market players, and an increase in the use of automated systems due to benefits such as the reduced risk of contamination and elimination of human error, among others.

The market is divided into end-use segments such as clinical chemistry analysis, photometry and fluorometry, immunoassay analysis, electrolyte analysis, and others.

Demand for Automated Workstations is growing rapidly

Automated workstations are expected to account for a sizable portion of lab automation market revenue, with integrated workflow solutions in particularly high demand. As clinical diagnostic studies become more sophisticated, the demand for advanced imaging, monitoring, and cell detection systems grows, providing an opportunity for key manufacturers to launch new solutions.

BioMerieux is a well-known name in the field of automated integrated workstations. WASPLab® integrated lab optimization and automation platforms are marketed by the company, which provides a flexible automated specimen processing and reading solution. It includes the PhenoMATRIXTM embedded AI and the ColibriTM colony selection module. These types of solutions greatly aid lab technicians in streamlining their workflows.

Lab Automation Market- Competitive Landscape

The majority of the aforementioned players' primary expansion strategy includes the introduction of new automation equipment and software that can be customized to meet industry-specific requirements. Furthermore, strategic partnerships, collaborations with academic and research institutes, as well as the government, and the acquisition of small-scale players are used.

  • Thermo Fisher Scientific, Inc. launched the Rapid EZ DNA-Seq library preparation kit in February 2020, offering PCR-free generation of sequencing-ready libraries for NGS.
  • Danaher Corporation (Beckman Coulter, Inc.) signed a marketing agreement with Clever Culture Systems (CCS), a leader in microbiology automation using AI, in July 2020, to promote the APAS Independence in their suite of lab automation solutions.
  • Becton, Dickinson, and Company announced in February 2020 that the BD Kiestra ReadA has been approved by the US Food and Drug Administration (FDA). This stand-alone device increases operational efficiency in clinical microbiology laboratories by automating redundant plate management tasks while providing accuracy via standardized digital image acquisition.

Key Segments Covered in the Lab Automation Market Report

  • By Product :

    • Lab Automation Equipment
      • Automated Workstations
      • Automated Liquid Handling
      • Automated Integrated Workstations
      • Pipetting Systems
      • Reagent Dispensers
      • Microplate Washers
    • Automated Microplate Readers
      • Multi-mode Microplate Readers
      • Single-mode Microplate Readers
    • Automated ELISA Systems
    • Automated Nucleic Acid Purification Systems
    • Lab Automation Software & Informatics
      • Workstation/Unit Automation Software
      • Laboratory Information Management Systems (LIMS)
      • Electronic Laboratory Notebook
      • Scientific Data Management System
  • By Application :

    • Drug Discovery
    • Clinical Diagnostics
    • Genomics Solutions
    • Proteomics Solutions
  • By End User :

    • Biotechnology & Pharmaceutical Industries
    • Research & Academic Institutes
    • Hospitals & Diagnostic Laboratories
    • Forensic Laboratories
    • Environmental Testing Labs
    • Food & Beverage Industry
  • By Region :

    • North America 
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East & Africa

Table of Content

  • 1. Global - Executive Summary
  • 2. Global Overview
  • 3. Market Risks and Trends Assessment
  • 4. Market Background and Foundation Data Points
  • 5. Global Demand (US$ Mn) Analysis 2015 to 2021 and Forecast, 2022 to 2032
  • 6. Global Analysis 2015 to 2021 and Forecast 2022 to 2032, By Product
    • 6.1. Equipment
      • 6.1.1. Automated Workstations
        • 6.1.1.1. Automated Liquid Handling
        • 6.1.1.2. Automated Integrated Workstations
        • 6.1.1.3. Pipetting Systems
        • 6.1.1.4. Reagent Dispensers
        • 6.1.1.5. Microplate Washers
      • 6.1.2. Microplate Readers
        • 6.1.2.1. Multi-mode Microplate Readers
        • 6.1.2.2. Single-mode Microplate Readers
      • 6.1.3. Automated ELISA Systems
      • 6.1.4. Automated Nucleic Acid Purification Systems
    • 6.2. Software & Informatics
      • 6.2.1. Workstation/Unit Automation Software
      • 6.2.2. Laboratory Information Management Systems (LIMS)
      • 6.2.3. Electronic Laboratory Notebook
      • 6.2.4. Scientific Data Management Systems
  • 7. Global Analysis 2015 to 2021 and Forecast 2022 to 2032, by Application
    • 7.1. Drug Discovery
    • 7.2. Clinical Diagnostics
    • 7.3. Genomics Solutions
    • 7.4. Proteomics Solutions
  • 8. Global Analysis 2015 to 2021 and Forecast 2022 to 2032, by End User
    • 8.1. Biotechnology & Pharmaceutical Industries
    • 8.2. Research & Academic Institutes
    • 8.3. Hospitals & Diagnostic Laboratories
    • 8.4. Forensic Laboratories
    • 8.5. Environmental Testing Labs
    • 8.6. Food & Beverage Industry
  • 9. Global Analysis 2015 to 2021 and Forecast 2022 to 2032, by Region
    • 9.1. North America
    • 9.2. Latin America
    • 9.3. Europe
    • 9.4. East Asia
    • 9.5. South Asia & Oceania
    • 9.6. Middle East and Africa (MEA)
  • 10. North America Analysis 2015 to 2021 and Forecast 2022 to 2032
  • 11. Latin America Analysis 2015 to 2021 and Forecast 2022 to 2032
  • 12. Europe Analysis 2015 to 2021 and Forecast 2022 to 2032
  • 13. East Asia Analysis 2015 to 2021 and Forecast 2022 to 2032
  • 14. South Asia & Oceania Analysis 2015 to 2021 and Forecast 2022 to 2032
  • 15. Middle East and Africa Analysis 2015 to 2021 and Forecast 2022 to 2032
  • 16. Market Structure Analysis
  • 17. Competition Analysis
    • 17.1. Thermo Fisher Scientific
    • 17.2. Agilent Technologies
    • 17.3. PerkinElmer
    • 17.4. Hudson Robotics
    • 17.5. Qiagen NV
    • 17.6. F. Hoffmann-La Roche Ltd.
    • 17.7. Hamilton Robotics
    • 17.8. Siemens Healthineers
    • 17.9. Becton Dickinson and Company
    • 17.10. Bio-Rad Laboratories
    • 17.11. FORMULATRIX
    • 17.12. BioMérieux SA
    • 17.13. Danaher Corporation
  • 18. Assumptions and Acronyms Used
  • 19. Research Methodology

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 1: Global Value (US$ Mn) Analysis, by Product, 2015 to 2021

Table 2: Global Value (US$ Mn) Analysis, by Product, 2022 to 2032

Table 3: Global Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2032

Table 4: Global Value (US$ Mn) Analysis, by Application, 2015 to 2021

Table 5: Global Value (US$ Mn) Analysis, by Application, 2022 to 2032

Table 6: Global Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2032

Table 7: Global Value (US$ Mn) Analysis, by End User, 2015 to 2021

Table 8: Global Value (US$ Mn) Analysis, by End User, 2022 to 2032

Table 9: Global Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2032

Table 10: Global Value (US$ Mn) Analysis, by Region, 2015 to 2021

Table 11: Global Value (US$ Mn) Analysis, by Region, 2022 to 2032

Table 12: Global Value (US$ Mn) Opportunity Analysis, by Region, 2022 to 2032

Table 13: North America Value (US$ Mn) Analysis, by Country, 2015 to 2021

Table 14: North America Value (US$ Mn) Analysis, by Country, 2022 to 2032

Table 15: North America Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2032

Table 16: North America Value (US$ Mn) Analysis, by Product, 2015 to 2021

Table 17: North America Value (US$ Mn) Analysis, by Product, 2022 to 2032

Table 18: North America Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2032

Table 19: North America Value (US$ Mn) Analysis, by Application, 2015 to 2021

Table 20: North America Value (US$ Mn) Analysis, by Application, 2022 to 2032

Table 21: North America Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2032

Table 22: North America Value (US$ Mn) Analysis, by End User, 2015 to 2021

Table 23: North America Value (US$ Mn) Analysis, by End User, 2022 to 2032

Table 24: North America Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2032

Table 25: Latin America Value (US$ Mn) Analysis, by Country, 2015 to 2021

Table 26: Latin America Value (US$ Mn) Analysis, by Country, 2022 to 2032

Table 27: Latin America Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2032

Table 28: Latin America Value (US$ Mn) Analysis, by Product, 2015 to 2021

Table 29: Latin America Value (US$ Mn) Analysis, by Product, 2022 to 2032

Table 30: Latin America Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2032

Table 31: Latin America Value (US$ Mn) Analysis, by Application, 2015 to 2021

Table 32: Latin America Value (US$ Mn) Analysis, by Application, 2022 to 2032

Table 33: Latin America Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2032

Table 34: Latin America Value (US$ Mn) Analysis, by End User, 2015 to 2021

Table 35: Latin America Value (US$ Mn) Analysis, by End User, 2022 to 2032

Table 36: Latin America Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2032

Table 37: Europe Value (US$ Mn) Analysis, by Country, 2015 to 2021

Table 38: Europe Value (US$ Mn) Analysis, by Country, 2022 to 2032

Table 39: Europe Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2032

Table 40: Europe Value (US$ Mn) Analysis, by Product, 2015 to 2021

Table 41: Europe Value (US$ Mn) Analysis, by Product, 2022 to 2032

Table 42: Europe Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2032

Table 43: Europe Value (US$ Mn) Analysis, by Application, 2015 to 2021

Table 44: Europe Value (US$ Mn) Analysis, by Application, 2022 to 2032

Table 45: Europe Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2032

Table 46: Europe Value (US$ Mn) Analysis, by End User, 2015 to 2021

Table 47: Europe Value (US$ Mn) Analysis, by End User, 2022 to 2032

Table 48: Europe Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2032

Table 49: East Asia Value (US$ Mn) Analysis, by Country, 2015 to 2021

Table 50: East Asia Value (US$ Mn) Analysis, by Country, 2022 to 2032

Table 51: East Asia Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2032

Table 52: East Asia Value (US$ Mn) Analysis, by Product, 2015 to 2021

Table 53: East Asia Value (US$ Mn) Analysis, by Product, 2022 to 2032

Table 54: East Asia Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2032

Table 55: East Asia Value (US$ Mn) Analysis, by Application, 2015 to 2021

Table 56: East Asia Value (US$ Mn) Analysis, by Application, 2022 to 2032

Table 57: East Asia Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2032

Table 58: East Asia Value (US$ Mn) Analysis, by End User, 2015 to 2021

Table 59: East Asia Value (US$ Mn) Analysis, by End User, 2022 to 2032

Table 60: East Asia Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2032

Table 61: South Asia & Oceania Value (US$ Mn) Analysis, by Country, 2015 to 2021

Table 62: South Asia & Oceania Value (US$ Mn) Analysis, by Country, 2022 to 2032

Table 63: South Asia & Oceania Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2032

Table 64: South Asia & Oceania Value (US$ Mn) Analysis, by Product, 2015 to 2021

Table 65: South Asia & Oceania Value (US$ Mn) Analysis, by Product, 2022 to 2032

Table 66: South Asia & Oceania Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2032

Table 67: South Asia & Oceania Value (US$ Mn) Analysis, by Application, 2015 to 2021

Table 68: South Asia & Oceania Value (US$ Mn) Analysis, by Application, 2022 to 2032

Table 69: South Asia & Oceania Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2032

Table 70: South Asia & Oceania Value (US$ Mn) Analysis, by End User, 2015 to 2021

Table 71: South Asia & Oceania Value (US$ Mn) Analysis, by End User, 2022 to 2032

Table 72: South Asia & Oceania Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2032

Table 73: MEA Value (US$ Mn) Analysis, by Country, 2015 to 2021

Table 74: MEA Value (US$ Mn) Analysis, by Country, 2022 to 2032

Table 75: MEA Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2032

Table 76: MEA Value (US$ Mn) Analysis, by Product, 2015 to 2021

Table 77: MEA Value (US$ Mn) Analysis, by Product, 2022 to 2032

Table 78: MEA Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2032

Table 79: MEA Value (US$ Mn) Analysis, by Application, 2015 to 2021

Table 80: MEA Value (US$ Mn) Analysis, by Application, 2022 to 2032

Table 81: MEA Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2032

Table 82: MEA Value (US$ Mn) Analysis, by End User, 2015 to 2021

Table 83: MEA Value (US$ Mn) Analysis, by End User, 2022 to 2032

Table 84: MEA Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2032

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 1: Global Value (US$ Mn) Historical Analysis, 2015 to 2021

Figure 2: Global Value (US$ Mn) Forecast and Analysis, 2022 to 2032

Figure 3: Global Value Y-o-Y Growth and Forecast, 2015 to 2032

Figure 4: Global Incremental $ Opportunity, 2022 to 2032

Figure 5: Global Share and BPS Analysis by Product, 2022 & 2032

Figure 6: Global Y-o-Y Growth Projections by Product, 2022 to 2032

Figure 7: Global Attractiveness Analysis by Product, 2022 to 2032

Figure 8: Global Share and BPS Analysis by Application, 2022 & 2032

Figure 9: Global Y-o-Y Growth Projections by Application, 2022 to 2032

Figure 10: Global Attractiveness Analysis by Application, 2022 to 2032

Figure 11: Global Share and BPS Analysis by End User, 2022 & 2032

Figure 12: Global Y-o-Y Growth Projections by End User, 2022 to 2032

Figure 13: Global Attractiveness Analysis by End User, 2022 to 2032

Figure 14: Global Share and BPS Analysis by Region, 2022 & 2032

Figure 15: Global Y-o-Y Growth Projections by Region, 2022 to 2032

Figure 16: Global Attractiveness Analysis by Region, 2022 to 2032

Figure 17: North America Value (US$ Mn) Historical Analysis, 2015 to 2021

Figure 18: North America Value (US$ Mn) Forecast and Analysis, 2022 to 2032

Figure 19: North America Value Y-o-Y Growth and Forecast, 2015 to 2032

Figure 20: North America Incremental $ Opportunity, 2022 to 2032

Figure 21: North America Share Analysis by Country, 2022 & 2032

Figure 22: North America Y-o-Y Growth Projection by Country, 2022 to 2032

Figure 23: North America Attractiveness Analysis by Country, 2022 to 2032

Figure 24: North America Share and BPS Analysis by Product, 2022 & 2032

Figure 25: North America Y-o-Y Growth Projections by Product, 2022 to 2032

Figure 26: North America Attractiveness Analysis by Product, 2022 to 2032

Figure 27: North America Share and BPS Analysis by Application, 2022 & 2032

Figure 28: North America Y-o-Y Growth Projections by Application, 2022 to 2032

Figure 29: North America Attractiveness Analysis by Application, 2022 to 2032

Figure 30: North America Share and BPS Analysis by End User, 2022 & 2032

Figure 31: North America Y-o-Y Growth Projections by End User, 2022 to 2032

Figure 32: North America Attractiveness Analysis by End User, 2022 to 2032

Figure 33: Latin America Value (US$ Mn) Historical Analysis, 2015 to 2021

Figure 34: Latin America Value (US$ Mn) Forecast and Analysis, 2022 to 2032

Figure 35: Latin America Value Y-o-Y Growth and Forecast, 2015 to 2032

Figure 36: Latin America Incremental $ Opportunity, 2022 to 2032

Figure 37: Latin America Share Analysis by Country, 2022 & 2032

Figure 38: Latin America Y-o-Y Growth Projection by Country, 2022 to 2032

Figure 39: Latin America Attractiveness Analysis by Country, 2022 to 2032

Figure 40: Latin America Share and BPS Analysis by Product, 2022 & 2032

Figure 41: Latin America Y-o-Y Growth Projections by Product, 2022 to 2032

Figure 42: Latin America Attractiveness Analysis by Product, 2022 to 2032

Figure 43: Latin America Share and BPS Analysis by Application, 2022 & 2032

Figure 44: Latin America Y-o-Y Growth Projections by Application, 2022 to 2032

Figure 45: Latin America Attractiveness Analysis by Application, 2022 to 2032

Figure 46: Latin America Share and BPS Analysis by End User, 2022 & 2032

Figure 47: Latin America Y-o-Y Growth Projections by End User, 2022 to 2032

Figure 48: Latin America Attractiveness Analysis by End User, 2022 to 2032

Figure 49: Europe Value (US$ Mn) Historical Analysis, 2015 to 2021

Figure 50: Europe Value (US$ Mn) Forecast and Analysis, 2022 to 2032

Figure 51: Europe Value Y-o-Y Growth and Forecast, 2015 to 2032

Figure 52: Europe Incremental $ Opportunity, 2022 to 2032

Figure 53: Europe Share Analysis by Country, 2022 & 2032

Figure 54: Europe Y-o-Y Growth Projection by Country, 2022 to 2032

Figure 55: Europe Attractiveness Analysis by Country, 2022 to 2032

Figure 56: Europe Share and BPS Analysis by Product, 2022 & 2032

Figure 57: Europe Y-o-Y Growth Projections by Product, 2022 to 2032

Figure 58: Europe Attractiveness Analysis by Product, 2022 to 2032

Figure 59: Europe Share and BPS Analysis by Application, 2022 & 2032

Figure 60: Europe Y-o-Y Growth Projections by Application, 2022 to 2032

Figure 61: Europe Attractiveness Analysis by Application, 2022 to 2032

Figure 62: Europe Share and BPS Analysis by End User, 2022 & 2032

Figure 63: Europe Y-o-Y Growth Projections by End User, 2022 to 2032

Figure 64: Europe Attractiveness Analysis by End User, 2022 to 2032

Figure 65: East Asia Value (US$ Mn) Historical Analysis, 2015 to 2021

Figure 66: East Asia Value (US$ Mn) Forecast and Analysis, 2022 to 2032

Figure 67: East Asia Value Y-o-Y Growth and Forecast, 2015 to 2032

Figure 68: East Asia Incremental $ Opportunity, 2022 to 2032

Figure 69: East Asia Share Analysis by Country, 2022 & 2032

Figure 70: East Asia Y-o-Y Growth Projection by Country, 2022 to 2032

Figure 71: East Asia Attractiveness Analysis by Country, 2022 to 2032

Figure 72: East Asia Share and BPS Analysis by Product, 2022 & 2032

Figure 73: East Asia Y-o-Y Growth Projections by Product, 2022 to 2032

Figure 74: East Asia Attractiveness Analysis by Product, 2022 to 2032

Figure 75: East Asia Share and BPS Analysis by Application, 2022 & 2032

Figure 76: East Asia Y-o-Y Growth Projections by Application, 2022 to 2032

Figure 77: East Asia Attractiveness Analysis by Application, 2022 to 2032

Figure 78: East Asia Share and BPS Analysis by End User, 2022 & 2032

Figure 79: East Asia Y-o-Y Growth Projections by End User, 2022 to 2032

Figure 80: East Asia Attractiveness Analysis by End User, 2022 to 2032

Figure 81: South Asia & Oceania Value (US$ Mn) Historical Analysis, 2015 to 2021

Figure 82: South Asia & Oceania Value (US$ Mn) Forecast and Analysis, 2022 to 2032

Figure 83: South Asia & Oceania Value Y-o-Y Growth and Forecast, 2015 to 2032

Figure 84: South Asia & Oceania Incremental $ Opportunity, 2022 to 2032

Figure 85: South Asia & Oceania Share Analysis by Country, 2022 & 2032

Figure 86: South Asia & Oceania Y-o-Y Growth Projection by Country, 2022 to 2032

Figure 87: South Asia & Oceania Attractiveness Analysis by Country, 2022 to 2032

Figure 88: South Asia & Oceania Share and BPS Analysis by Product, 2022 & 2032

Figure 89: South Asia & Oceania Y-o-Y Growth Projections by Product, 2022 to 2032

Figure 90: South Asia & Oceania Attractiveness Analysis by Product, 2022 to 2032

Figure 91: South Asia & Oceania Share and BPS Analysis by Application, 2022 & 2032

Figure 92: South Asia & Oceania Y-o-Y Growth Projections by Application, 2022 to 2032

Figure 93: South Asia & Oceania Attractiveness Analysis by Application, 2022 to 2032

Figure 94: South Asia & Oceania Share and BPS Analysis by End User, 2022 & 2032

Figure 95: South Asia & Oceania Y-o-Y Growth Projections by End User, 2022 to 2032

Figure 96: South Asia & Oceania Attractiveness Analysis by End User, 2022 to 2032

Figure 97: MEA Value (US$ Mn) Historical Analysis, 2015 to 2021

Figure 98: MEA Value (US$ Mn) Forecast and Analysis, 2022 to 2032

Figure 99: MEA Value Y-o-Y Growth and Forecast, 2015 to 2032

Figure 100: MEA Incremental $ Opportunity, 2022 to 2032

Figure 101: MEA Share Analysis by Country, 2022 & 2032

Figure 102: MEA Y-o-Y Growth Projection by Country, 2022 to 2032

Figure 103: MEA Attractiveness Analysis by Country, 2022 to 2032

Figure 104: MEA Share and BPS Analysis by Product, 2022 & 2032

Figure 105: MEA Y-o-Y Growth Projections by Product, 2022 to 2032

Figure 106: MEA Attractiveness Analysis by Product, 2022 to 2032

Figure 107: MEA Share and BPS Analysis by Application, 2022 & 2032

Figure 108: MEA Y-o-Y Growth Projections by Application, 2022 to 2032

Figure 109: MEA Attractiveness Analysis by Application, 2022 to 2032

Figure 110: MEA Share and BPS Analysis by End User, 2022 & 2032

Figure 111: MEA Y-o-Y Growth Projections by End User, 2022 to 2032

Figure 112: MEA Attractiveness Analysis by End User, 2022 to 2032

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

- FAQs -

What was the market worth for lab automation in 2021?

As of 2021, the lab automation market was worth US$ 1.8 Billion.

At what value is the lab automation industry likely to close by 2022?

Fact.MR foresees lab automation demand to reach US$ 2 Billion in 2022.

What was the documented value CAGR for the market from 2015 to 2021?

From 2015-2021, the lab automation market surged at a 6.1% CAGR.

At what percentage will the market for lab automation rise until 2032?

From 2022-2032, Fact.MR expects lab automation revenue to flourish at a 7% CAGR

What is the expected market value for lab automation in 2032?

In 2032, lab automation market worth is poised to reach US$ 3.94 Billion.

How do growth rate for lab automation in North America?

The U.S lab automation market is growing at a rate of 5.3% from 2022 to 2032.

Will Asia Pacific emerge as an opportunistic market for lab automation?

Asia Pacific is expected to register maximum growth, documenting a 7.3% CAGR through 2032.

Lab Automation Market

Schedule a Call